Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Neurobo Pharmaceuticals Inc have a median target of 22.00, with a high estimate of 48.00 and a low estimate of 10.00. The median estimate represents a 574.85% increase from the last price of 3.26.
High | 1,372.4% | 48.00 |
Med | 574.8% | 22.00 |
Low | 206.7% | 10.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | -141.18% |
Average growth rate | +71.50% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼